CORE A The Analytical Core A functions as an integral part of the Superfund Research Center at UC Davis. Methods are developed to detect biomarkers of exposure to hazardous substances in the environment, and to assess the impact these substances have on human health. Core A provides the analytical support critical to solving collaborative research problems. Sophisticated instrumentation is used to develop chromatographic and spectrometric methods necessary for the elucidation of biomarkers. Specifically, Core A provides compound identification and assesses chemical purity; identifies remediation products, potential ligands associated with xenobiotics, and targeted metabolites (Projects 1, 4 and 5); provides reference methods for biosensor validation and immunochemical detection of environmental substances (Projects 2 and 3); and provides metabolomics support (Projects 1, 4 and 5). Core A offers assistance to investigators interested in obtaining and interpreting spectra generated at other campus service laboratories such as the NMR and proteomic facility. Instrument training and education is also offered to investigators in conjunction with the Training Core (Core E). A range of innovative services is offered by Core A, with emphasis on analytical method development. The Core has 3 LC-MS/MSs, 1 LC-ToF-MS, 2 GC-MSs, and an Accelerator Mass Spectrometer (AMS). Hazardous substances and their metabolites are measured in human or animal samples, and can be detected with high sensitivity. For example, the AMS has a detection limit of ~1 amol 14C, and is 100 000 times more sensitive than the traditional liquid scintillation counter. Another technique used to assess biomarkers of hazardous substances is metabolomics analysis, a high throughput method that screens for metabolites within biological samples. Here, an innovative LC-MS/MS method is used to screen for 87 lipid metabolites to determine the consequence of hazardous substances on regulatory lipids. Core A is a significant collaborative component of the UC Davis Superfund Center, driving forward Superfund research projects. This Core advances the analytical techniques required to assess biomarkers of hazardous substances. Researchers within Core A continue to work on expanding the metabolomics platform in order to provide more sensitivity and higher throughput. The AMS throughput is also increasing, allowing for efficient sample analysis. By providing innovative and advanced technology, this Core is a valued part of the research program. It generates solutions to problems surrounding the environmental contamination of hazardous substances, and interrogates the risk these substances pose on human health.

Public Health Relevance

CORE A The Analytical Core A plays a central role in the UC Davis Superfund Research Center through its collaborative involvement with all of the Center Projects. Core A uses advanced instrumentation to develop analytical methods for characterizing environmental contamination from hazardous chemicals, and provides tools to assess the impact of hazardous chemicals on human health.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Hazardous Substances Basic Research Grants Program (NIEHS) (P42)
Project #
5P42ES004699-32
Application #
9917778
Study Section
Special Emphasis Panel (ZES1)
Project Start
Project End
Budget Start
2020-04-01
Budget End
2021-03-31
Support Year
32
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of California Davis
Department
Type
DUNS #
047120084
City
Davis
State
CA
Country
United States
Zip Code
95618
Taha, Ameer Y; Hennebelle, Marie; Yang, Jun et al. (2018) Regulation of rat plasma and cerebral cortex oxylipin concentrations with increasing levels of dietary linoleic acid. Prostaglandins Leukot Essent Fatty Acids 138:71-80
Hill 3rd, Thomas; Rice, Robert H (2018) DUOX expression in human keratinocytes and bronchial epithelial cells: Influence of vanadate. Toxicol In Vitro 46:257-264
Kodani, Sean D; Wan, Debin; Wagner, Karen M et al. (2018) Design and Potency of Dual Soluble Epoxide Hydrolase/Fatty Acid Amide Hydrolase Inhibitors. ACS Omega 3:14076-14086
Ren, Qian; Ma, Min; Yang, Jun et al. (2018) Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson's disease. Proc Natl Acad Sci U S A 115:E5815-E5823
Pecic, Stevan; Zeki, Amir A; Xu, Xiaoming et al. (2018) Novel piperidine-derived amide sEH inhibitors as mediators of lipid metabolism with improved stability. Prostaglandins Other Lipid Mediat 136:90-95
Yamanashi, Haruto; Boeglin, William E; Morisseau, Christophe et al. (2018) Catalytic activities of mammalian epoxide hydrolases with cis and trans fatty acid epoxides relevant to skin barrier function. J Lipid Res 59:684-695
Wang, Fuli; Zhang, Hongyong; Ma, Ai-Hong et al. (2018) COX-2/sEH Dual Inhibitor PTUPB Potentiates the Antitumor Efficacy of Cisplatin. Mol Cancer Ther 17:474-483
Napimoga, M H; Rocha, E P; Trindade-da-Silva, C A et al. (2018) Soluble epoxide hydrolase inhibitor promotes immunomodulation to inhibit bone resorption. J Periodontal Res 53:743-749
Blöcher, René; Wagner, Karen M; Gopireddy, Raghavender R et al. (2018) Orally Available Soluble Epoxide Hydrolase/Phosphodiesterase 4 Dual Inhibitor Treats Inflammatory Pain. J Med Chem 61:3541-3550
Hao, Lei; Kearns, Jamie; Scott, Sheyenne et al. (2018) Indomethacin Enhances Brown Fat Activity. J Pharmacol Exp Ther 365:467-475

Showing the most recent 10 out of 1149 publications